Can-Fite BioPharma Ltd.

Foreign Filer Report • Nov 11, 2025

_________ false

��-���� ������� ��"�	2 381
CAN-FITE BIOPHARMA LTD
Corporation no: 512022153	14960
- - -

	Israel Securities Authority			Tel Aviv Stock Exchange		C003 ( Public )		Reported via MAGNA:	10/11/2025
	www.isa.gov.il			www.tase.co.il				Reference:	2025-02-085545	Time of broadcast: 16:14 16:14

---

The corporation scheduled the publication of the report to 10/11/2025 23:15Other Report or AnnouncementRegulation 5 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

	The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report on	On November 10, 2025, a Special General Meeting of Shareholders of Can-Fite BioPharma Ltd. approved each of the two proposals brought before the Company�s shareholders at the meeting, in accordance with the majority required for each proposal. Each

ea026475301-6k_canfiteEDGAR1_Bannerless_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
2025-02-083348     2025-02-074141
- - -
Stock Exchange/Market: -1	Date of revision of form structure: 06/08/2024
Address: Bareket 10 , Petach-Tikva 47190   , Tel: 03-9241114 , 03-9213501 Fax: 03-9249378
E-mail address: motti@canfite.co.il   Company site: www.canfite.com
Previous names of reporting entity:
Name of the Signatory: FARBSTEIN MORDECHAI Position of Signatory in the reporting corporation: Chief Operating Officer & CFO Name of Employer Company:
Address: Maharal street 10 , Tel Aviv 6248110 Telephone: 052-8998671 Facsimile: E-mail: Motti@canfite.co.il 1